Type 2 diabetes (T2D) is among the most prevalent chronic metabolic disorders worldwide - driven by insulin resistance, pancreatic dysfunction, obesity, and unhealthy lifestyles
As we continue to learn and adapt, Semaglutides place in the therapeutic arsenal against diabetes and obesity is likely to become even more prominent, helping countless individuals lead healthier, more fulfilling lives
Evidence indicates that structured physical activity, particularly resistance training, can mitigate these effects and optimize long-term metabolic outcomes ( Table 1 )
Unknowns and downsides exist, including potential side effects, high cost, weight regain after stopping the drug, non-response by some people and possible muscle and bone density loss
Semaglutide is an effective and widely used medication, but its impact on gastric motility requires careful consideration
Daily habits still matter, and combining medication with routines like balanced eating, movement, and progress tracking helps protect long-term results
